Project Information

Reference Number 19990116
Project Title Generation of Humanized Single Gene- Encoded Antibodies, with Varied Effector Functions for Direct Use as Anti- Tumor Reagents, and for Production of Immunoliposomes: DESICLON and TRANSEXPRESS
Project Type Contained Use
Status Completed
Name of Institution National Institute of Molecular Biology and Biotechnology (NIMBB), UP Diliman, Quezon City
Cooperating Institution National Institutes of Health
Supervising IBC UP Diliman-IBC
Project Leader(s) Ameurfina D. Santos, Associate Professor 5
Experimental Facility/Site IRRI, Philippines
Purpose / Objectives To develop engineered, humanized antibodies for cancer therapy and diagnosis.
Biosafety measures Biosafety Level 1 (BL1)
Conditions for Approval 1. The required level of containment for the proposed activities is BL2.
2. The activities should only be carried out once the BL2 facility is completed.
3. UP Diliman- IBC shall review the design and inspect the facility to ensure that it conforms with the standard set for BL2 containment.
4. Personnel working on project should have a baseline level, zero collected before the experiments Actually takes place.
Date Received 1999-10-14
Date of Approval 1999-11-03


Regulated Materials

Regulated Materials N/A
Source N/A
Subject Request of Dr. Elma Llaguno for proposal endorsement
Requesting Party Dr. Elma Llaguno, Chairman, UP Diliman IBC
Action of NCBP Approved for implementation